Results of treatment of the radicular form of sciatica with a vaccine obtained from Escherichia coli
Markiewicz, M.
Polski Tygodnik Lekarski 26(34): 1318-1319
1971
ISSN/ISBN: 0032-3756 PMID: 4938968 Document Number: 41390
Document emailed within 1 workday
Related Documents
Moon, H.W.; Rogers, D.G.; Rose, R. 1988: Effects of an orally administered live Escherichia coli pilus vaccine on duration of lacteal immunity to enterotoxigenic Escherichia coli in swine American Journal of Veterinary Research 49(12): 2068-2071Wennerås, C.; Czerkinsky, C.; Svennerholm, A.M. 1995: Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine Advances in Experimental Medicine and Biology 371b: 1641-1644
Matušková, V.; Kolář, P.; Vysloužilová, D.; Vlková, E.; Dušek, L.; Kandrnal, V.; Jarkovský, J.; Uher, M. 2012: Ranibizumab in the ARMD wet form of age-related macular degeneration treatment - two years results obtained from the AMADEuS Registry Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 68(5): 171-177
D'Eshougues, J.R.; Clarisse, J.; Delandsheer, J.M.; Delcambre, B.; Duquennoy, A.; Warot, P. 1974: Management of radicular sciatica Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 19(Special Issue): 413-421
Michael-Meese, M.; Klie, H.; Schöll, W. 1980: Escherichia coli R live vaccine Suicolplex "Dessau" Archiv für Experimentelle Veterinarmedizin 34(1): 109-114
Tseng, C.C. 1981: Studies on pathogenic Escherichia coli. Part 8. Purification and properties of exotoxin from capsular polysaccharide-synthesizing Escherichia coli Journal of the Formosan Medical Association 80(9): 866-872
Verbenko, V.N.; Kuznetsova, L.V.; Kalinin, V.L. 1994: Mutant alleles for radioresistance form the Escherichia coli strain Gam(r)444): cloning and preliminary characteristics Genetika 30(6): 756-762
Vernozy-Rozand, C. 1999: Verotoxin-producing Escherichia coli (VTEC) and Escherichia coli O157:H7 in medicine and food industry Annales de Biologie Clinique 57(5): 507-515
DeGraves, F.J.; Fetrow, J. 1991: Partial budget analysis of vaccinating dairy cattle against coliform mastitis with an Escherichia coli J5 vaccine Journal of the American Veterinary Medical Association 199(4): 451-455
Ivanova, E.I.; Popkova, S.M.; Dzhioev, I.P.; Rakova, E.B.; Dolgikh, V.V.; Savel'kaeva, M.V.; Nemchenko, U.M.; Bukharova, E.V.; Serdiuk, L.V. 2015: The detection of occurrence rate of genes coding capability to form pili binding in auto-strains of Escherichia coli Klinicheskaia Laboratornaia Diagnostika 60(1): 52-55
Shemiakin, M.F.; Shumilov, V.Iu. 1981: Protection of segments of replicative form I of phiX174 phage DNA recognized by HindII, BspRI, and AluI restrictases by Escherichia coli RNA-polymerase Molekuliarnaia Biologiia 15(5): 1144-1157
Mukhopadhyay, A.; Bhatia, P.K.; Majumdar, S.S. 1998: Preliminary studies with recombinant chorionic gonadotropin beta-subunit produced in Escherichia coli for use as an antigen in a birth control vaccine American Journal of Reproductive Immunology 39(3): 172-182
Neguţ, E.A.; Durbacă, S.; Usein, C.R.; Geamal, S.; Pătru, C.; Cârlan, D.; Barbu, M. 2000: Investigation of the results obtained following repeated boosters with Di-Te vaccine in HIV positive children Roumanian Archives of Microbiology and Immunology 59(1-2): 5-17
Turk, J.; Maddox, C.; Fales, W.; Ostlund, E.; Miller, M.; Johnson, G.; Pace, L.; Turnquist, S.; Kreeger, J. 1998: Examination for heat-labile, heat-stable, and Shiga-like toxins and for the eaeA gene in Escherichia coli isolates obtained from dogs dying with diarrhea: 122 cases (1992-1996) Journal of the American Veterinary Medical Association 212(11): 1735-1736
Holzhauer, C.; Wertenbroek, C.J. 1979: Results obtained using an attenuated bovine syncytial virus vaccine against bronchopneumonia of yearlings Tijdschrift Voor Diergeneeskunde 104(17): 674-678
Petrescu, A.L.; Cajal, N. 1984: Results obtained with the NIVGRIP inactivated influenza vaccine applicable by nasal and/or oral route Virologie 35(4): 307-314
Penninckx, M.; Gigot, D. 1979: The illicit permeation of N-delta-phosphonoacetyl-L-ornithine under the form of a tripeptide. Selective inhibition in vivo of Escherichia coli L-ornithine carbamoyltransferase Archives Internationales de Physiologie et de Biochimie 87(1): 198-199
Dima, V.F.; Ionescu, M.D.; Palade, R.; Balotescu, C.; Becheanu, G.; Dima, S.V. 2001: Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine Roumanian Archives of Microbiology and Immunology 60(1): 27-54
Ricciardi, G.; Graziano, G. 1990: Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel Bollettino dell'Istituto Sieroterapico Milanese 69(2): 385-390
Stepanova, N.F.; Andreeva, I.V.; Kiriushkina, A.A.; Kondrat'ev, I.S.; Likhoded, L.I. 1977: Intergeneric conjugational crossing of Escherichia coli with Salmonella typhimurium. II. Transfer of a polA1 mutation from Escherichia coli to Salmonella typhimurium and its phenotypic expression in the salmonella genome Genetika 13(12): 2189-2194